Statement Of Cash Flows [Abstract]

Marinomed Biotech AG - Filing #1079021

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities
1,971,000 EUR
35,000 EUR
Cash flows from (used in) operating activities
4,866 EUR
6,885 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
9,188,000 EUR
3,964 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
1,800 EUR
8,000 EUR
Payments of lease liabilities, classified as financing activities
231,000 EUR
787,000 EUR
Cash flows from (used in) financing activities
2,380 EUR
8,006 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
346,000 EUR
22,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
3,405 EUR
2,813 EUR
Cash and cash equivalents
5,802 EUR
9,207 EUR
12,020 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.